|
TMEM126A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.50449999999758E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52369999999858E-05 |
| Normal-vs-Stage2 |
1.809380E-01 |
| Normal-vs-Stage3 |
1.804260E-04 |
| Normal-vs-Stage4 |
2.19240000043364E-07 |
| Stage1-vs-Stage2 |
1.573010E-01 |
| Stage1-vs-Stage3 |
8.903200E-01 |
| Stage1-vs-Stage4 |
1.541700E-02 |
| Stage2-vs-Stage3 |
1.608240E-01 |
| Stage2-vs-Stage4 |
6.241900E-03 |
| Stage3-vs-Stage4 |
3.672100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.96380000003916E-07 |
| Normal-vs-AfricanAmerican |
4.564600E-03 |
| Normal-vs-Asian |
8.590100E-04 |
| Caucasian-vs-AfricanAmerican |
9.849800E-01 |
| Caucasian-vs-Asian |
5.751200E-01 |
| AfricanAmerican-vs-Asian |
7.135200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71751999999969E-05 |
| Normal-vs-Female |
2.043000E-04 |
| Male-vs-Female |
9.492300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.07590000000213E-05 |
| Normal-vs-Age(41-60Yrs) |
8.09470000000534E-05 |
| Normal-vs-Age(61-80Yrs) |
2.000500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.340400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.488800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.819800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.373200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.186000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.116800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.479000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.145200E-01 |
| Classical-VS-Follicular |
6.754300E-04 |
| Classical-VS-Other |
5.952600E-01 |
| Classical-VS-Normal |
1.27449999998142E-07 |
| Tall-VS-Follicular |
1.248400E-02 |
| Tall-VS-Other |
5.583200E-01 |
| Tall-VS-Normal |
5.416900E-04 |
| Follicular-VS-Other |
1.576380E-01 |
| Follicular-VS-Normal |
3.791800E-01 |
| Other-VS-Normal |
1.013900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.563600E-04 |
| Normal-vs-N1 |
3.42360000016306E-07 |
| N0-vs-N1 |
1.190110E-02 |
|
|
